After virus mutations spurred the FDA to yank Eli Lilly’s COVID-19 drug from the market, public health experts told Becker’s their predictions for the future of COVID-19 treatments.
Read the full post on Becker's Hospital Review - Healthcare News
The COVID-19 treatment landscape
